Back
Denali Therapeutics Stock Price Chart
The Tech Disruption Wall Street Isn't Talking About...Yet
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
39
DNLI
Denali Therapeutics
Last Price:
28.61
Seasonality Move:
20.85%
7 Day Trial
ALL ACCESS PASS
$
7
Supercharge Your Portfolio with This High-Traction AI Startup
Learn More- The current trend is moderately bullish and DNLI is experiencing slight selling pressure.
Denali Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.93 | Sell |
| 20-day SMA: | 29.18 | Sell |
| 50-day SMA: | 25.93 | Buy |
| 200-day SMA: | 21.16 | Buy |
| 8-day EMA: | 28.94 | Sell |
| 20-day EMA: | 28.55 | Buy |
| 50-day EMA: | 26.55 | Buy |
| 200-day EMA: | 23.03 | Buy |
Denali Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.83 | Buy |
| Relative Strength Index (14 RSI): | 54.3 | Buy |
| Chaikin Money Flow: | -56409 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.21 - 30.49) | Buy |
| Bollinger Bands (100): | (20.39 - 26.93) | Buy |
Denali Therapeutics Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Denali Therapeutics Stock
Is Denali Therapeutics Stock a Buy?
- Denali Therapeutics share price is 28.63 while DNLI 8-day simple moving average is 28.93, which is a Sell signal.
- The stock price of DNLI is 28.63 while Denali Therapeutics 20-day SMA is 29.18, which makes it a Sell.
- Denali Therapeutics 50-day simple moving average is 25.93 while DNLI share price is 28.63, making it a Buy technically.
- DNLI stock price is 28.63 and Denali Therapeutics 200-day simple moving average is 21.16, creating a Buy signal.
DNLI Technical Analysis vs Fundamental Analysis
Sell
39
Denali Therapeutics (DNLI)
is a Sell
Is Denali Therapeutics a Buy or a Sell?
-
Denali Therapeutics stock is rated a Sell
The current Denali Therapeutics [DNLI] share price is $28.63. The Score for DNLI is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
Denali Therapeutics Stock Info
Market Cap:
4.1B
Price in USD:
28.63
Share Volume:
360.53K
Denali Therapeutics 52-Week Range
52-Week High:
32.13
52-Week Low:
14.56
Sell
39
Denali Therapeutics (DNLI)
is a Sell
Denali Therapeutics Share Price Forecast
-
What is the Denali Therapeutics stock price today?
The Denali Therapeutics stock price is 28.63 USD today. -
Will DNLI stock go up or go down?
Denali Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Denali Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Denali Therapeutics is overvalued.
Is Denali Therapeutics Stock a Buy?
- Denali Therapeutics share price is 28.63 while DNLI 8-day exponential moving average is 28.94, which is a Sell signal.
- The stock price of DNLI is 28.63 while Denali Therapeutics 20-day EMA is 28.55, which makes it a Buy.
- Denali Therapeutics 50-day exponential moving average is 26.55 while DNLI share price is 28.63, making it a Buy technically.
- DNLI stock price is 28.63 and Denali Therapeutics 200-day simple moving average is 23.03, creating a Buy signal.
Fundamental Analysis of Denali Therapeutics
Is Denali Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.52 per share, and a decrease next year of $0.07 per share.
Technical Analysis of Denali Therapeutics
Should I short Denali Therapeutics stock?
- DNLI Moving Average Covergence Divergence (MACD) indicator is 0.83, suggesting Denali Therapeutics is a Buy
- Denali Therapeutics Relative Strength Index (RSI) is 54.3, which suggest Denali Therapeutics is overbought
- The Bollinger Bands (25) for Denali Therapeutics is (26.21 - 30.49), which suggest Denali Therapeutics is a Buy
- The Bollinger Bands (100) for Denali Therapeutics is (20.39 - 26.93), which suggest Denali Therapeutics is a Buy
* Denali Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.